Moszyńska-Zielińska M, Sobotkowski J, Gottwald L, Kordek R, Błasińska-Morawiec M, Ciałkowska-Rysz A. Primary B-cell lymphoma of the uterine corpus – case report and review of the literature. Menopause Review/Przegląd Menopauzalny. 2008;7(4):202-204.
APA
Moszyńska-Zielińska, M., Sobotkowski, J., Gottwald, L., Kordek, R., Błasińska-Morawiec, M., & Ciałkowska-Rysz, A. (2008). Primary B-cell lymphoma of the uterine corpus – case report and review of the literature. Menopause Review/Przegląd Menopauzalny, 7(4), 202-204.
Chicago
Moszyńska-Zielińska, Małgorzata, Janusz Sobotkowski, Leszek Gottwald, Radzisław Kordek, Maria Błasińska-Morawiec, and Aleksandra Ciałkowska-Rysz. 2008. "Primary B-cell lymphoma of the uterine corpus – case report and review of the literature". Menopause Review/Przegląd Menopauzalny 7 (4): 202-204.
Harvard
Moszyńska-Zielińska, M., Sobotkowski, J., Gottwald, L., Kordek, R., Błasińska-Morawiec, M., and Ciałkowska-Rysz, A. (2008). Primary B-cell lymphoma of the uterine corpus – case report and review of the literature. Menopause Review/Przegląd Menopauzalny, 7(4), pp.202-204.
MLA
Moszyńska-Zielińska, Małgorzata et al. "Primary B-cell lymphoma of the uterine corpus – case report and review of the literature." Menopause Review/Przegląd Menopauzalny, vol. 7, no. 4, 2008, pp. 202-204.
Vancouver
Moszyńska-Zielińska M, Sobotkowski J, Gottwald L, Kordek R, Błasińska-Morawiec M, Ciałkowska-Rysz A. Primary B-cell lymphoma of the uterine corpus – case report and review of the literature. Menopause Review/Przegląd Menopauzalny. 2008;7(4):202-204.
Primary B-cell lymphoma is a lymphoblastic B-cell malignant tumour with very aggressive course. Its abdominal form involving internal genital organs is rare. We report the case of a 67-year-old woman treated due to abdominal B-cell lymphoma. The patient presented postmenopausal uterine bleeding. During laparotomy total abdominal hysterectomy with bilateral salpingo-oophorectomy was performed. Pathologic examination revealed a primary uterine: diffuse large B-cell lymphoma (DLBCL), CD20 (+). After surgery, immunochemotherapy (R-CHOP) was conducted. The patient, 12 months after surgical treatment, is still under control in our Oncological Centre. No signs of recurrence have been detected so far.